Author: psychmedcomms

The BRAIN Unit and National Centre for Mental Health (NCMH) will co-host an event on Saturday 20 April to celebrate the role patient and public involvement groups play in research. The event will bring together public and patient involvement groups, researchers and the general public…

On Thursday 7 December, our BRAIN Involve lead Dr Cheney Drew delivered a public lecture on the use of advanced therapies in Huntington’s and Parkinson’s Disease. The lecture was part of the Science in Health public lecture series, hosted by the School of Medicine at…

My name is Dr Cheney Drew, and I am a Research Fellow and Senior Clinical Trials Manager based in Centre for Trials Research in Cardiff University.   About me Outside of my work at Cardiff University, I have many passions, from ultra-marathon running to arts…

As we move away from the challenges of COVID we have been able to harness the benefits of online tools and reimagine our involvement and engagement delivery. In this article, we shine a light on some of the PPI activities from 2022 - 23.  Our…

We are delighted to have successfully delivered the UniQure Phase I/II gene therapy trial focussing on knocking down Huntington protein production within neurons in Huntington’s Disease, to three patients in Cardiff. This gene therapy is potentially curative or significantly slowing disease progression in this fatal…

As a Clinical Research Fellow in Neurosurgery, Susruta is working on identifying strategies for optimising the effective delivery of cell and gene-therapies to the brain, under the supervision of Professor Liam Gray.   About me I am a neurosurgical trainee currently taking time out of…

Participants, funders and principal investigators came together to discuss the key findings of a recent Cardiff University study, and to present resources that people with Parkinson's disease and their support partners can use when considering research participation. The LEARN study stands for 'listening to the…

BRAIN researchers have co-edited a book which examines the progress of cell therapies in the treatment of neurodegenerative diseases, published last November. Cell therapies are a promising development for the treatment of neurodegenerative diseases (NDDs) such as Huntington’s and Parkinson’s, which occur when nerve cells…

Lauren Griffiths is a Research Technician at Swansea University. Her recent research has centred around cholesterol, its function in the brain, and understanding its role in neurodegenerative diseases. Cholesterol is an essential molecule in the body, and especially in the brain, where it is the…

Around 145,000 people live with Parkinson’s in the UK, and it's the fastest-growing neurological condition in the world. For World Parkinson's Day, Dr Emma Lane from the BRAIN Unit discusses the disease and some things you may not know. What is Parkinson's disease? Parkinson's disease…